N/A
Completed N=120
Enhancing a Sustainable Pharmacy-based Immunization Program in Two States
Source: ClinicalTrials.gov NCT02615470 ↗Enrolled (actual)
120
Serious AEs
—
Results posted
Aug 2019
Primary outcomePrimary: Number of Herpes Zoster and Pneumococcal Vaccinations Administered — 4.50; 1; 1.50; 2 vaccine doses — p==0.202
Summary
The study's aim is to enhance current immunization activities in community pharmacies through targeting the two most commonly available non-seasonal vaccines in community pharmacies, namely pneumococcal and herpes zoster vaccination services. The study will compare the change in the number of pneumococcal and herpes zoster vaccinations administered in pharmacy from the corresponding 6-month period prior to the intervention to the 6-month intervention period between intervention pharmacies and the control pharmacies.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Herpes Zoster and Pneumococcal Vaccinations Administered |
4.50; 1; 1.50; 2; 3.5; 0 | =0.202 |
| SECONDARY Number of Strategies Implemented to Promote Immunization Activities |
8; 7 | 0.048 sig |
Eligibility Criteria
Inclusion Criteria
- Alabama and California community pharmacies
- Must provide in-store prescription-dispensing service
- Must provide pneumococcal vaccine and/or herpes zoster
Exclusion Criteria
- Must have no plan to close or change the ownership in the next 12 months
Data sourced from ClinicalTrials.gov (NCT02615470). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.